| Name | Title | Contact Details |
|---|
Aulisa Medical USA, Inc., located in Palo Alto, integrates medical device science and information communication technologies to provide smart medical solutions for the evolving patient care landscape. The company specializes in wireless, wearable, FDA-cleared vital-signs measuring devices with continuous, cloud-based, patient monitoring and alarm systems. Through the development of new products, Aulisa continues to focus on growing the application of Digital Health, collecting large amounts of patient data for big data analytics and Artificial Intelligence (AI) to medical applications. The company is a subsidiary of Taiwan Aulisa Medical Devices Technologies, Inc., headquartered in Taipei, Taiwan, where a Research & Development center and operational headquarters was established in 2013.
Internal Medical Group is a Jacksonville, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
southern cc ems is a West Grove, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
NeuroOne Medical Technologies Incorporated (Ticker: NMTC) is a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, initially targeting epilepsy. Today, our attention is on the development and commercialization of patented thin-film, cortical electrode technology for intracranial electroencephalography (iEEG) and depth electrodes for stereoelectroencephalography (sEEG) recording of brain activity. The products currently available in these categories have significant limitations such as low recording resolution and high risk of infection. NeuroOne believes our technology can address these unmet needs upon initial commercialization with pipeline technology to advance the field by enabling minimally invasive techniques and all-in-one diagnostic and therapeutic options. While our initial focus is Epilepsy, future applications in Parkinson`s disease, Essential tremors, and Dystonia are within sight. NeuroOne technologies will be presented to a well-defined market, eager for the advancement they bring. There are 188 hospital centers licensed to perform epilepsy surgical procedures in the U.S. The current addressable market opportunity for is approximately $525.6 million. As more patients choose the minimally invasive procedures made available by NeuroOne technology, the future opportunity is estimated to be approximately $14.9 billion with full market penetration.
Howard Medical is a Ellisville, MS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.